Home  »  Trending   »  Here’s How Your Trade Johnson & Johnson...

Here’s How Your Trade Johnson & Johnson (JNJ) Aggressively Right Now

Johnson & Johnson (NYSE:JNJ) went up by 0.11% from its latest closing price compared to the recent 1-year high of $186.69. The company’s stock price has collected 2.05% of gains in the last five trading sessions. The Wall Street Journal reported on 11/02/22 that J&J Makes a $16.6 Billion Bet on Heart Pumps to Lift Medical-Device Sales

Is It Worth Investing in Johnson & Johnson (NYSE :JNJ) Right Now?

Johnson & Johnson (NYSE:JNJ) scored a price-to-earnings ratio above its average ratio, recording 24.64 x from its present earnings ratio. Plus, the 36-month beta value for JNJ is at 0.57.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


JNJ currently public float of 2.61B and currently shorts hold a 0.47% ratio of that float. Today, the average trading volume of JNJ was 7.00M shares.

JNJ’s Market Performance

JNJ stocks went up by 2.05% for the week, with a monthly jump of 3.69% and a quarterly performance of 5.91%, while its annual performance rate touched 10.16%. The volatility ratio for the week stands at 0.92% while the volatility levels for the past 30 days are set at 1.50% for Johnson & Johnson. The simple moving average for the period of the last 20 days is 2.21% for JNJ stocks with a simple moving average of 2.77% for the last 200 days.

Analysts’ Opinion of JNJ

Many brokerage firms have already submitted their reports for JNJ stocks, with Credit Suisse repeating the rating for JNJ by listing it as a “Neutral.” The predicted price for JNJ in the upcoming period, according to Credit Suisse is $170 based on the research report published on November 18th of the current year 2022.

Barclays, on the other hand, stated in their research note that they expect to see JNJ reach a price target of $175. The rating they have provided for JNJ stocks is “Equal Weight” according to the report published on October 18th, 2022.

BofA Securities gave a rating of “Neutral” to JNJ, setting the target price at $178 in the report published on October 14th of the current year.

JNJ Trading at 5.14% from the 50-Day Moving Average

After a stumble in the market that brought JNJ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.19% of loss for the given period.

Volatility was left at 1.50%, however, over the last 30 days, the volatility rate increased by 0.92%, as shares surge +2.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.50% upper at present.

During the last 5 trading sessions, JNJ rose by +2.05%, which changed the moving average for the period of 200-days by +3.21% in comparison to the 20-day moving average, which settled at $173.42. In addition, Johnson & Johnson saw 3.47% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at JNJ starting from Taubert Jennifer L, who sale 76,923 shares at the price of $176.78 back on Nov 22. After this action, Taubert Jennifer L now owns 126,456 shares of Johnson & Johnson, valued at $13,598,402 using the latest closing price.

Decker Robert J, the Controller, CAO of Johnson & Johnson, sale 16,928 shares at $175.00 during a trade that took place back on Nov 18, which means that Decker Robert J is holding 15,473 shares at $2,962,400 based on the most recent closing price.

Stock Fundamentals for JNJ

Equity return is now at value 25.60, with 10.70 for asset returns.